“…Pharmacological inhibition of the cysteinyl leukotrienes via LT antagonists, LY255283 and montelukast sodium, or ALOX5 inhibitor, BW-B70C, reduced the profibrotic effect of senescent cells on naive fibroblasts in vitro ( Wiley et al, 2019 ) and attenuated TNFα-induced up-regulation of SA-β-Gal, p53, p21, and PAI-1 expression in primary human chondrocytes associated with osteoarthritis ( Song et al, 2018 ). Increase in COX-2 activity has been shown to be associated with aging ( Badawi et al, 2005 ; Chung et al, 1999 ; Baek et al, 2001 ). For example, COX-2 expression was upregulated in kidney, liver, heart and prostrate in old rodents ( Hayek et al, 1997 ; Kim et al, 2001 ; Badawi et al, 2004 ; Choi et al, 2014 ; Tung et al, 2015 ), and in aging human tissues as well, especially kidney and skin ( Melk et al, 2004 ; Kang et al, 2006 ; Surowiak et al, 2014 ).…”